Source of circulating progesterone in prepubertal ewes.

J. Berardinelli,R. Dailey,R. Butcher,E. Inskeep

DOI: https://doi.org/10.1095/BIOLREPROD22.2.233

1980-03-01

Biology of Reproduction

Abstract:

What problem does this paper attempt to address?

Myelin and axon pathology in multiple sclerosis assessed by myelin water and multi-shell diffusion imaging

Reza Rahmanzadeh,Po-Jui Lu,Muhamed Barakovic,Matthias Weigel,Pietro Maggi,Thanh D Nguyen,Simona Schiavi,Alessandro Daducci,Francesco La Rosa,Sabine Schaedelin,Martina Absinta,Daniel S Reich,Pascal Sati,Yi Wang,Meritxell Bach Cuadra,Ernst-Wilhelm Radue,Jens Kuhle,Ludwig Kappos,Cristina Granziera

DOI: https://doi.org/10.1093/brain/awab088

IF: 14.5

2021-03-09

Brain

Abstract:Abstract Damage to the myelin sheath and the neuroaxonal unit is a cardinal feature of multiple sclerosis; however, a detailed characterization of the interaction between myelin and axon damage in vivo remains challenging. We applied myelin water and multi-shell diffusion imaging to quantify the relative damage to myelin and axons (i) among different lesion types; (ii) in normal-appearing tissue; and (iii) across multiple sclerosis clinical subtypes and healthy controls. We also assessed the relation of focal myelin/axon damage with disability and serum neurofilament light chain as a global biological measure of neuroaxonal damage. Ninety-one multiple sclerosis patients (62 relapsing-remitting, 29 progressive) and 72 healthy controls were enrolled in the study. Differences in myelin water fraction and neurite density index were substantial when lesions were compared to healthy control subjects and normal-appearing multiple sclerosis tissue: both white matter and cortical lesions exhibited a decreased myelin water fraction and neurite density index compared with healthy (P < 0.0001) and peri-plaque white matter (P < 0.0001). Periventricular lesions showed decreased myelin water fraction and neurite density index compared with lesions in the juxtacortical region (P < 0.0001 and P < 0.05). Similarly, lesions with paramagnetic rims showed decreased myelin water fraction and neurite density index relative to lesions without a rim (P < 0.0001). Also, in 75% of white matter lesions, the reduction in neurite density index was higher than the reduction in the myelin water fraction. Besides, normal-appearing white and grey matter revealed diffuse reduction of myelin water fraction and neurite density index in multiple sclerosis compared to healthy controls (P < 0.01). Further, a more extensive reduction in myelin water fraction and neurite density index in normal-appearing cortex was observed in progressive versus relapsing-remitting participants. Neurite density index in white matter lesions correlated with disability in patients with clinical deficits (P < 0.01, beta = −10.00); and neurite density index and myelin water fraction in white matter lesions were associated to serum neurofilament light chain in the entire patient cohort (P < 0.01, beta = −3.60 and P < 0.01, beta = 0.13, respectively). These findings suggest that (i) myelin and axon pathology in multiple sclerosis is extensive in both lesions and normal-appearing tissue; (ii) particular types of lesions exhibit more damage to myelin and axons than others; (iii) progressive patients differ from relapsing-remitting patients because of more extensive axon/myelin damage in the cortex; and (iv) myelin and axon pathology in lesions is related to disability in patients with clinical deficits and global measures of neuroaxonal damage.

neurosciences,clinical neurology
Proteomics analysis of periplaque and chronic inactive multiple sclerosis lesions

Jordan M. Wilkins,Kiran K. Mangalaparthi,Brian C. Netzel,William A. Sherman,Yong Guo,Alicja Kalinowska-Lyszczarz,Akhilesh Pandey,Claudia F. Lucchinetti

DOI: https://doi.org/10.3389/fnmol.2024.1448215

2024-08-22

Frontiers in Molecular Neuroscience

Abstract:Background: Multiple sclerosis (MS) is a demyelinating disease of the central nervous system characterized by increased inflammation and immune responses, oxidative injury, mitochondrial dysfunction, and iron dyshomeostasis leading to demyelination and axonal damage. In MS, incomplete remyelination results in chronically demyelinated axons and degeneration coinciding with disability. This suggests a failure in the ability to remyelinate in MS, however, the precise underlying mechanisms remain unclear. We aimed to identify proteins whose expression was altered in chronic inactive white matter lesions and periplaque white matter in MS tissue to reveal potential pathophysiological mechanisms. Methods: Laser capture microdissection coupled to proteomics was used to interrogate spatially altered changes in formalin-fixed paraffin-embedded brain tissue from three chronic MS individuals and three controls with no apparent neurological complications. Histopathological maps guided the capture of inactive lesions, periplaque white matter, and cortex from chronic MS individuals along with corresponding white matter and cortex from control tissue. Label free quantitation by liquid chromatography tandem mass spectrometry was used to discover differentially expressed proteins between the various brain regions. Results: In addition to confirming loss of several myelin-associated proteins known to be affected in MS, proteomics analysis of chronic inactive MS lesions revealed alterations in myelin assembly, metabolism, and cytoskeletal organization. The top altered proteins in MS inactive lesions compared to control white matter consisted of PPP1R14A, ERMN, SIRT2, CARNS1, and MBLAC2. Conclusion: Our findings highlight proteome changes in chronic inactive MS white matter lesions and periplaque white matter, which may be crucial for proper myelinogenesis, bioenergetics, focal adhesions, and cellular function. This study highlights the importance and feasibility of spatial approaches such as laser capture microdissection-based proteomics analysis of pathologically distinct regions of MS brain tissue. Identification of spatially resolved changes in the proteome of MS brain tissue should aid in the understanding of pathophysiological mechanisms and the development of novel therapies.

neurosciences
History of diagnostic enzymology: a review of significant investigations.

P. Wolf

DOI: https://doi.org/10.1016/J.CCA.2006.02.043

2006-07-31

Abstract:
Examining the relative contribution of slow-burning inflammation and chronic demyelination to axonal damage in chronic multiple sclerosis lesions

Samuel Klistorner,Michael H Barnett,John Parratt,Con Yiannikas,Alexander Klistorner

DOI: https://doi.org/10.1016/j.msard.2024.105828

2024-08-22

Abstract:Background and objectives: Slow-burning inflammation at the edge, and chronic demyelination at the core, of established multiple sclerosis (MS) lesions are potential mediators of disease progression. However, their relative contribution to progressive axonal damage has not been explored. Therefore, in this study, we investigated the comparative contribution of slow-burning inflammation and chronic demyelination to axonal attrition within MS lesions by measuring progressive tissue rarefaction. In addition, we use the visual system as a model to investigate the effect of chronic demyelination on the acceleration of axonal death in a sub-group of patients with unilateral optic neuritis. Methods: Pre- and post-gadolinium 3D-T1, 3D FLAIR, diffusion tensor images, Optical Coherence tomography and multifocal visual evoked potentials were acquired from 52 relapsing-remitting MS patients who completed at least 5 years follow-up. Lesion expansion was measured using custom software, and the rate of tissue rarefication inside lesion core was assessed by measuring increase of normalized mean diffusivity (nMD). Axonal loss was also examined in eyes with severe optic nerve demyelination. Results: Among the 361 lesions analyzed, 104 were expanding (a minimum of 4 % expansion per year) and 257 were stable. Expanding lesions showed a significantly higher rate of progressive tissue rarefication inside lesion (1.12 % per year) core compared to stable lesions (0.21 % per year, p = 0.01). The magnitude of nMD change was significantly correlated with the rate of lesion expansion (r = 0.4, p < 0.001). Analysis of retinal ganglion cells in eyes with severe optic nerve demyelination (Inter-eye latency delay of >10 ms) revealed a similar rate of axonal loss (0.19 %) to the degree of tissue rarefaction observed in stable lesions (0.21 %). Discussion: The results of the study suggest that the slow-burning inflammation at the lesion's edge (as measured by lesion expansion), is likely to have a greater impact on tissue damage (as measured by nMD change), when compared to stable chronically demyelinated lesions. The similar modest degree of tissue damage was also observed in chronically demyelinated fibers of the optic nerve.
Comparing two versions of the Schedule for Evaluation of Individual Quality of Life in patients with advanced cancer

L. Wettergren,Å. Lindblad,B. Glimelius,L. Ring

DOI: https://doi.org/10.3109/0284186X.2011.557088

IF: 4.311

2011-05-16

Acta Oncologica

Abstract:Abstract Background. The aim was to compare two individualized patient reported outcomes or the Schedule for the Evaluation of Individual Quality of Life – Direct Weighting (SEIQoL-DW) measuring quality of life in general, and the disease-related version (SEIQoL-DR) measuring quality of life related to disease. Both instruments have been used in clinical practice settings within oncology. The instruments were compared with regard to feasibility, the areas nominated by patients as important and patients’ ratings of how they were doing in these areas (Index scores). Material and methods. The study included 40 patients with gastrointestinal cancer. All patients completed both versions of the instrument on a touch screen computer in relation to a medical consultation. Firstly, the participants were invited to nominate the five domains she/he currently considered to be most important in life. Secondly, they were asked to rate how they were doing in each of these domains. Finally, they were asked to quantify the relative importance of each area. Cohen's effect sizes were calculated to illuminate the clinical importance of mean value differences. Results. Both instruments took less than ten minutes to complete and the procedure was considered feasible by both patients and interviewers. The proportion of patients nominating the same areas in the two versions did not differ, however, the SEIQoL-DW Index score was significantly higher than the corresponding score for the SEIQoL-DR. The detected difference in the mean score measured by effect size was medium. Conclusion. The magnitude of the effect size of the difference in Index score imply that the two versions tap into different constructs, i.e. quality of life (QoL) versus health-related QoL (HRQL), supporting the construct validity of the two versions of the instrument. The SEIQoL-DW and the SEIQoL-DR should be considered as complementary rather than interchangeable when used in patients with cancer.
Evaluating brain damage in multiple sclerosis with simultaneous multi-angular-relaxometry of tissue

Biao Xiang,Jie Wen,Robert E Schmidt,Alexander L Sukstanskii,Daniel Mamah,Dmitriy A Yablonskiy,Anne H Cross

DOI: https://doi.org/10.1002/acn3.51621

Abstract:Objective: Multiple sclerosis (MS) is a common demyelinating central nervous system disease. MRI methods that can quantify myelin loss are needed for trials of putative remyelinating agents. Quantitative magnetization transfer MRI introduced the macromolecule proton fraction (MPF), which correlates with myelin concentration. We developed an alternative approach, Simultaneous-Multi-Angular-Relaxometry-of-Tissue (SMART) MRI, to generate MPF. Our objective was to test SMART-derived MPF metric as a potential imaging biomarker of demyelination. Methods: Twenty healthy control (HC), 11 relapsing-remitting MS (RRMS), 22 progressive MS (PMS), and one subject with a biopsied tumefactive demyelinating lesion were scanned at 3T using SMART MRI. SMART-derived MPF metric was determined in normal-appearing cortical gray matter (NAGM), normal-appearing subcortical white matter (NAWM), and demyelinating lesions. MPF metric was evaluated for correlations with physical and cognitive test scores. Comparisons were made between HC and MS and between MS subtypes. Furthermore, correlations were determined between MPF and neuropathology in the biopsied person. Results: SMART-derived MPF in NAGM and NAWM were lower in MS than HC (p < 0.001). MPF in NAGM, NAWM and lesions differentiated RRMS from PMS (p < 0.01, p < 0.001, p < 0.001, respectively), whereas lesion volumes did not. MPF in NAGM, NAWM and lesions correlated with the Expanded Disability Status Scale (p < 0.01, p < 0.001, p < 0.001, respectively) and nine-hole peg test (p < 0.001, p < 0.001, p < 0.01, respectively). MPF was lower in the histopathologically confirmed inflammatory demyelinating lesion than the contralateral NAWM and increased in the biopsied lesion over time, mirroring improved clinical performance. Interpretation: SMART-derived MPF metric holds potential as a quantitative imaging biomarker of demyelination and remyelination.
Multimodal Coherent Anti-Stokes Raman Scattering Microscopy Reveals Microglia-Associated Myelin and Axonal Dysfunction in Multiple Sclerosis-Like Lesions in Mice.

Jaime Imitola,Daniel Cote,Stine Rasmussen,X. Sunney Xie,Yingru Liu,Tanuja Chitnis,Richard L. Sidman,Charles. P. Lin,Samia J. Khoury

DOI: https://doi.org/10.1117/1.3533312

IF: 3.758

2011-01-01

Journal of Biomedical Optics

Abstract:Myelin loss and axonal degeneration predominate in many neurological disorders; however, methods to visualize them simultaneously in live tissue are unavailable. We describe a new imaging strategy combining video rate reflectance and fluorescence confocal imaging with coherent anti-Stokes Raman scattering (CARS) microscopy tuned to CH(2) vibration of myelin lipids, applied in live tissue of animals with chronic experimental autoimmune encephalomyelitis (EAE). Our method allows monitoring over time of demyelination and neurodegeneration in brain slices with high spatial resolution and signal-to-noise ratio. Local areas of severe loss of lipid signal indicative of demyelination and loss of the reflectance signal from axons were seen in the corpus callosum and spinal cord of EAE animals. Even in myelinated areas of EAE mice, the intensity of myelin lipid signals is significantly reduced. Using heterozygous knock-in mice in which green fluorescent protein replaces the CX(3)CR1 coding sequence that labels central nervous system microglia, we find areas of activated microglia colocalized with areas of altered reflectance and CARS signals reflecting axonal injury and demyelination. Our data demonstrate the use of multimodal CARS microscopy for characterization of demyelinating and neurodegenerative pathology in a mouse model of multiple sclerosis, and further confirm the critical role of microglia in chronic inflammatory neurodegeneration.
Seizures Worsen Stroke Outcome: New Evidence from a Large Sample

M. Koubeissi

DOI: https://doi.org/10.5698/1535-7597-15.1.30

2015-01-01

Epilepsy Currents

Abstract:Commentary Cerebrovascular disease is the most common cause of newonset epilepsy in older adults, accounting for more than one-third of all cases (1). The occurrence of seizures is known to affect stroke outcome. In a cohort of 5,027 stroke patients, seizures occurred in 2.7% of the cases and predicted increased mortality, longer hospitalization, and more disability (2). Seizures can occur early or late after an ischemic stroke. While approximately 3 to 5 percent of strokes are associated with a late seizure within the first year, up to 66% of these patients will develop epilepsy (4). In a population-based study in Rochester, MN, 535 consecutive persons were followed after their first cerebral infarction, and 33 (6%) had their first seizure within the first week (3). Of these, 78% had seizures in the first day after stroke. Risk for early seizures increased with anterior hemisphere location of infarct. New onset late seizures (past the first post-stroke week) occurred in 5%, and their risk was increased by early seizures and stroke recurrence, which are also risk factors for the development of epilepsy. Stroke has also been shown to increase the risk of status epilepticus. In one series, up to 25% of patients with status epilepticus presented with stroke (5). There are no guidelines about prophylactic treatment with antiseizure medications, or even treating after the first seizure, since the effect of a second seizure in an untreated stroke patient has not been proven to affect the overall outcome (4). Early and late seizures may differ both in terms of their underlying mechanisms and risk of epilepsy. Unlike early seizures that may result from biochemical imbalances, late seizures may result from gliotic scarring. In acute ischemia, glutamate-mediated excitotoxicity leads to an overload of intracellular calcium, which activates a number of intracellular enzymes and immediate early genes, eventually culminating in neuronal death. In surviving neurons, glutamate can induce epileptiform discharges (6). Thus, seizures in acute ischemia can increase the metabolic demand in the hypoxic tissue, potentially leading to increased infarct size (2). In contrast, late seizures may result from gliotic scarring with associated changes in membrane properties, deafferentation, selective neuronal loss, and collateral sprouting—all leading to hyperexcitability and increased synchronization of neuronal activity (7). In an attempt to test the hypothesis whether the pathophysiology of seizures after ischemic stroke is determined by the stage of the stroke, Huang et al. used the Registry of the Canadian Stroke Network, which collects data prospectively from multiple centers, to investigate the clinical features and outcomes of seizures occurring at stroke presentation (SSP) and seizures occurring after stroke but during hospitalization Influence of Seizures on Stroke Outcomes: A Large Multicenter Study.
A lymphocyte–microglia–astrocyte axis in chronic active multiple sclerosis

Martina Absinta,Dragan Maric,Marjan Gharagozloo,Thomas Garton,Matthew D. Smith,Jing Jin,Kathryn C. Fitzgerald,Anya Song,Poching Liu,Jing-Ping Lin,Tianxia Wu,Kory R. Johnson,Dorian B. McGavern,Dorothy P. Schafer,Peter A. Calabresi,Daniel S. Reich

DOI: https://doi.org/10.1038/s41586-021-03892-7

IF: 64.8

2021-09-08

Nature

Abstract:Multiple sclerosis (MS) lesions that do not resolve in the months after they form harbour ongoing demyelination and axon degeneration, and are identifiable in vivo by their paramagnetic rims on MRI scans1,2,3. Here, to define mechanisms underlying this disabling, progressive neurodegenerative state4,5,6 and foster development of new therapeutic agents, we used MRI-informed single-nucleus RNA sequencing to profile the edge of demyelinated white matter lesions at various stages of inflammation. We uncovered notable glial and immune cell diversity, especially at the chronically inflamed lesion edge. We define 'microglia inflamed in MS' (MIMS) and 'astrocytes inflamed in MS', glial phenotypes that demonstrate neurodegenerative programming. The MIMS transcriptional profile overlaps with that of microglia in other neurodegenerative diseases, suggesting that primary and secondary neurodegeneration share common mechanisms and could benefit from similar therapeutic approaches. We identify complement component 1q (C1q) as a critical mediator of MIMS activation, validated immunohistochemically in MS tissue, genetically by microglia-specific C1q ablation in mice with experimental autoimmune encephalomyelitis, and therapeutically by treating chronic experimental autoimmune encephalomyelitis with C1q blockade. C1q inhibition is a potential therapeutic avenue to address chronic white matter inflammation, which could be monitored by longitudinal assessment of its dynamic biomarker, paramagnetic rim lesions, using advanced MRI methods.

multidisciplinary sciences
Micro‐diffusely abnormal white matter: An early multiple sclerosis lesion phase with intensified myelin blistering

Antonio Luchicchi,Gema Muñoz‐Gonzalez,Saar T. Halperin,Eva Strijbis,Laura H. M. van Dijk,Chrisa Foutiadou,Florence Uriac,Piet M. Bouman,Maxime A. N. Schouten,Jason Plemel,Bert A. 't Hart,Jeroen J. G. Geurts,Geert J. Schenk

DOI: https://doi.org/10.1002/acn3.52015

IF: 5.43

2024-03-02

Annals of Clinical and Translational Neurology

Abstract:Objective Multiple sclerosis (MS) is a chronic central nervous system disease whose white matter lesion origin remains debated. Recently, we reported subtle changes in the MS normal appearing white matter (NAWM), presenting with an increase in myelin blisters and myelin protein citrullination, which may recapitulate some of the prodromal degenerative processes involved in MS pathogenesis. Here, to clarify the relevance of these changes for subsequent MS myelin degeneration we explored their prevalence in WM regions characterized by subtly reduced myelination (dubbed as micro‐diffusely abnormal white matter, mDAWM). Methods We used an in‐depth (immuno)histochemistry approach in 27 MS donors with histological presence of mDAWM and 5 controls. An antibody panel against degenerative markers was combined and the presence of myelin/axonal aberrations was analyzed and compared with the NAWM from the same cases/slices/regions. Results mDAWM‐defined areas exhibit ill‐defined borders, no signs of Wallerian degeneration, and they associate with visible veins. Remarkably, such areas present with augmented myelin blister frequency, enhanced prevalence of polar myelin phospholipids, citrullination, and degradation of myelin basic protein (MBP) when compared with the NAWM. Furthermore, enhanced reactivity of microglia/macrophages against citrullinated MBP was also observed in this tissue. Interpretation We report a new histologically defined early phase in MS lesion formation, namely mDAWM, which lacks signs of Wallerian pathology. These results support the prelesional nature of the mDAWM. We conceptualize that evolution to pathologically evident lesions comprises the previously documented imbalance of axo‐myelinic units (myelin blistering) leading to their degeneration and immune system activation by released myelin components.

neurosciences,clinical neurology
Digital Pathology Identifies Associations between Tissue Inflammatory Biomarkers and Multiple Sclerosis Outcomes

Benjamin Cooze,James Neal,Alka Vineed,J. C. Oliveira,Lauren Griffiths,K. H. Allen,Kristen Hawkins,Htoo Yadanar,Krisjanis Gerhards,Ildiko Farkas,Richard Reynolds,Owain Howell

DOI: https://doi.org/10.3390/cells13121020

IF: 6

2024-06-12

Cells

Abstract:Background: Multiple sclerosis (MS) is a clinically heterogeneous disease underpinned by inflammatory, demyelinating and neurodegenerative processes, the extent of which varies between individuals and over the course of the disease. Recognising the clinicopathological features that most strongly associate with disease outcomes will inform future efforts at patient phenotyping. Aims: We used a digital pathology workflow, involving high-resolution image acquisition of immunostained slides and opensource software for quantification, to investigate the relationship between clinical and neuropathological features in an autopsy cohort of progressive MS. Methods: Sequential sections of frontal, cingulate and occipital cortex, thalamus, brain stem (pons) and cerebellum including dentate nucleus (n = 35 progressive MS, females = 28, males = 7; age died = 53.5 years; range 38–98 years) were immunostained for myelin (anti-MOG), neurons (anti-HuC/D) and microglia/macrophages (anti-HLA). The extent of demyelination, neurodegeneration, the presence of active and/or chronic active lesions and quantification of brain and leptomeningeal inflammation was captured by digital pathology. Results: Digital analysis of tissue sections revealed the variable extent of pathology that characterises progressive MS. Microglia/macrophage activation, if found at a higher level in a single block, was typically elevated across all sampled blocks. Compartmentalised (perivascular/leptomeningeal) inflammation was associated with age-related measures of disease severity and an earlier death. Conclusion: Digital pathology identified prognostically important clinicopathological correlations in MS. This methodology can be used to prioritise the principal pathological processes that need to be captured by future MS biomarkers.

cell biology
Advanced MRI Measures of Myelin and Axon Volume Identify Repair in Multiple Sclerosis

Gretel Sanabria‐Diaz,Alessandro Cagol,Po‐Jui Lu,Muhamed Barakovic,Mario Ocampo‐Pineda,Xinjie Chen,Matthias Weigel,Esther Ruberte,Nina de Oliveira S. Siebenborn,Riccardo Galbusera,Sabine Schädelin,Pascal Benkert,Jens Kuhle,Ludwig Kappos,Lester Melie‐Garcia,Cristina Granziera

DOI: https://doi.org/10.1002/ana.27102

IF: 11.2

2024-10-11

Annals of Neurology

Abstract:Objective Pathological studies suggest that multiple sclerosis (MS) lesions endure multiple waves of damage and repair; however, the dynamics and characteristics of these processes are poorly understood in patients living with MS. Methods We studied 128 MS patients (75 relapsing–remitting, 53 progressive) and 72 healthy controls who underwent advanced magnetic resonance imaging and clinical examination at baseline and 2 years later. Magnetization transfer saturation and multi‐shell diffusion imaging were used to quantify longitudinal changes in myelin and axon volumes within MS lesions. Lesions were grouped into 4 classes (repair, damage, mixed repair damage, and stable). The frequency of each class was correlated to clinical measures, demographic characteristics, and levels of serum neurofilament light chain (sNfL). Results Stable lesions were the most frequent (n = 2,276; 44%), followed by lesions with patterns of "repair" (n = 1,352; 26.2%) and damage (n = 1,214; 23.5%). The frequency of "repair" lesion was negatively associated with disability (β = −0.04; p

neurosciences,clinical neurology
COMBINED USE OF NOVEL MR IMAGING AND FLUID BIOMARKERS REVEAL DETERMINANTS OF MYELIN AND AXONAL LOSS WITH AGING

Keenan Walker

DOI: https://doi.org/10.1093/geroni/igad104.1279

2023-12-01

Innovation in Aging

Abstract:Abstract Cerebral white matter damage is a feature of Alzheimer’s disease, vascular dementia, and other neurodegenerative conditions, yet little is known about the molecular underpinnings of key features of white matter pathology. In a series of studies we have used targeted assays and large-scale proteomics platforms to determine how biomarkers of Alzheimer’s disease pathology (Aß42/40 ratio; pTau181), neuronal injury (NfL), reactive astrogliosis (GFAP), and other disease processes relate to state-of-the-art diffusion-based MRI measures of brain myelin content and axonal density in cognitively unimpaired older adults. Using data from the Baltimore Longitudinal Study of Aging (BLSA) and the GESTALT study, we measured plasma biomarkers using the Quanterix Simoa assay (targeted measurement of 4 proteins) and the SomaScan proteomic platform (untargeted measurement of 7000 proteins). Additionally, participants underwent 3T MRI, from which measure of myelin content (defined by myelin water fraction [MWF]) and axonal density (defined by neurite density index [NDI]) were derived. We found an association between higher plasma GFAP and lower myelin content in temporal brain regions. Additionally, higher levels of NfL and GFAP were associated with lower total brain axonal density. Using untargeted proteomics, we identified a set of 155 plasma proteins that were associations with myelin content (P <0.05). Using these findings, we applied machine learning to construct a plasma protein-based predictor of brain myelin content, which we plan to validate in a cohort of individuals with multiple sclerosis: a condition characterized by demyelination.
Brain disconnectome mapping derived from white matter lesions and serum neurofilament light levels in multiple sclerosis: A longitudinal multicenter study

Henning H Rise,Synne Brune,Claudia Chien,Tone Berge,Steffan D Bos,Magí Andorrà,Irene Pulido Valdeolivas,Mona K Beyer,Piotr Sowa,Michael Scheel,Alexander U Brandt,Susanna Asseyer,Kaj Blennow,Mads L Pedersen,Henrik Zetterberg,Michel Thiebaut de Schotten,Maria Cellerino,Antonio Uccelli,Friedemann Paul,Pablo Villoslada,Hanne F Harbo,Lars T Westlye,Einar A Høgestøl

DOI: https://doi.org/10.1016/j.nicl.2022.103099

Abstract:Background and objectives: Connectivity-based approaches incorporating the distribution and magnitude of the extended brain network aberrations caused by lesions may offer higher sensitivity for axonal damage in patients with multiple sclerosis (MS) than conventional lesion characteristics. Using individual brain disconnectome mapping, we tested the longitudinal associations between putative imaging-based brain network aberrations and levels of serum neurofilament light chain (NfL) as a neuroaxonal injury biomarker. Methods: MS patients (n = 312, mean age 42.9 years, 71 % female) and healthy controls (HC) (n = 59, mean age 39.9 years, 78 % female) were prospectively enrolled at four European MS centres, and reassessed after two years (MS, n = 242; HC, n = 30). Post-processing of 3 Tesla (3 T) MRI data was performed at one centre using a harmonized pipeline, and disconnectome maps were calculated using BCBtoolkit based on individual lesion maps. Global disconnectivity (GD) was defined as the average disconnectome probability in each patient's white matter. Serum NfL concentrations were measured by single molecule array (Simoa). Robust linear mixed models (rLMM) with GD or T2-lesion volume (T2LV) as dependent variables, patient as a random factor, serum NfL, age, sex, timepoint for visit, diagnosis, treatment, and center as fixed factors were run. Results: rLMM revealed significant associations between GD and serum NfL (t = 2.94, p = 0.003), age (t = 4.21, p = 2.5 × 10-5), and longitudinal changes in NfL (t = -2.29, p = 0.02), but not for sex (t = 0.63, p = 0.53) or treatments (t = 0.80-0.83, p = 0.41-0.42). Voxel-wise analyses revealed significant associations between dysconnectivity in cerebellar and brainstem regions and serum NfL (t = 7.03, p < 0.001). Discussion: In our prospective multi-site MS cohort, rLMMs demonstrated that the extent of global and regional brain disconnectivity is sensitive to a systemic biomarker of axonal damage, serum NfL, in patients with MS. These findings provide a neuroaxonal correlate of advanced disconnectome mapping and provide a platform for further investigations of the functional and potential clinical relevance of brain disconnectome mapping in patients with brain disorders.
Axonal water fraction as marker of white matter injury in primary-progressive multiple sclerosis: a longitudinal study

M Margoni,M Petracca,S Schiavi,M Fabian,A Miller,F D Lublin,M Inglese

DOI: https://doi.org/10.1111/ene.13937

Abstract:Background and purpose: Diffuse white matter (WM) injury is prominent in primary-progressive multiple sclerosis (PP-MS) pathology and is a potential biomarker of disease progression. Diffusion kurtosis imaging allows the quantification of non-Gaussian water diffusion, providing metrics with high WM pathological specificity. The aim of this study was to characterize the pathological changes occurring in the normal-appearing WM of patients with PP-MS at baseline and at 1-year follow-up and to assess their impact on disability and short-term disease progression. Methods: A total of 26 patients with PP-MS and 20 healthy controls were prospectively enrolled. Diffusion kurtosis imaging single-shot echo-planar imaging (EPI) was acquired on a 3-T scanner (Philips Achieva, Best, The Netherlands) (voxel size, 2 × 2 × 2 mm3 , 30 directions for each b-value = 1000, 2000 s/mm2 and one b = 0 s/mm2 ). A two-compartment biophysical model of WM tract integrity was used to derive spatial maps of axonal water fraction (AWF), intra-axonal diffusivity, extra-axonal axial and radial diffusivities (De,axial , De,radial ) and tortuosity from the following WM tracts: corpus callosum (CC), corticospinal tract (CST) and posterior thalamic radiation (PTR). Results: At baseline, patients with PP-MS showed a widespread decrease of AWF, tortuosity and De,axial and an increase of De,radial in CC, CST and PTR (P ranging from 0.001 to 0.036). At 1-year follow-up, a significant AWF decrease was detected in the body of CC (P = 0.048), PTR (P = 0.008) and CST (P = 0.044). Baseline AWF values in CST significantly discriminated progressed from non-progressed patients (P = 0.021; area under the curve, 0.854). Conclusion: Based on its change over time and its relationship with disease progression, among the analyzed metrics, AWF seems the most sensitive metric of WM tissue damage in PP-MS and therefore it could be considered as a marker for monitoring disease progression.
Evolution of the thyrotropin receptor: a G protein coupled receptor with an intrinsic capacity to dimerize.

V. Kaczur,L. Puskás,M. Takács,I. Rácz,A. Szendrői,S. Tóth,Zsuzsanna Nagy,C. Szalai,C. Balázs,A. Falus,Bjarne Knudsen,N. Farid

DOI: https://doi.org/10.1016/S1096-7192(03)00036-2

IF: 4.204

2003-04-01

Molecular Genetics and Metabolism

Abstract:
Neuroimaging assessment of facility-bound severely-affected MS reveals the critical role of cortical gray matter pathology: results from the CASA–MS case-controlled study

Robert Zivadinov,Dejan Jakimovski,Alex Burnham,Jens Kuhle,Zachary Weinstock,Taylor R. Wicks,Murali Ramanathan,Tommaso Sciortino,Mark Ostrem,Christopher Suchan,Michael G. Dwyer,Jessica Reilly,Niels Bergsland,Ferdinand Schweser,Cheryl Kennedy,David Young-Hong,Svetlana Eckert,David Hojnacki,Ralph H. B. Benedict,Bianca Weinstock-Guttman

DOI: https://doi.org/10.1007/s00415-024-12420-2

2024-05-18

Journal of Neurology

Abstract:Background A subgroup of people with multiple sclerosis (pwMS) will develop severe disability. The pathophysiology underlying severe MS is unknown. The comprehensive assessment of severely affected MS (CASA–MS) was a case-controlled study that compared severely disabled in skilled nursing (SD/SN) (EDSS ≥ 7.0) to less-disabled (EDSS 3.0–6.5) community dwelling (CD) progressive pwMS, matched on age-, sex- and disease-duration (DDM). Objectives To identify neuroimaging and molecular biomarker characteristics that distinguish SD/SN from DDM–CD progressive pwMS. Methods This study was carried at SN facility and at a tertiary MS center. The study collected clinical, molecular (serum neurofilament light chain, sNfL and glial acidic fibrillary protein, sGFAP) and MRI quantitative lesion-, brain volume-, and tissue integrity-derived measures. Statistical analyses were controlled for multiple comparisons. Results 42 SD/SN and 42 DDM–CD were enrolled. SD/SN pwMS showed significantly lower cortical volume (CV) ( p < 0.001, d = 1.375) and thalamic volume ( p < 0.001, d = 0.972) compared to DDM–CD pwMS. In a logistic stepwise regression model, the SD/SN pwMS were best differentiated from the DDM–CD pwMS by lower CV ( p < 0.001) as the only significant predictor, with the accuracy of 82.3%. No significant differences between the two groups were observed for medulla oblongata volume, a proxy for spinal cord atrophy and white matter lesion burden, while there was a statistical trend for numerically higher sGFAP in SD/SN pwMS. Conclusions The CASA–MS study showed significantly more gray matter atrophy in severe compared to less-severe progressive MS.

clinical neurology
Molecular signature of different lesion types in the brain white matter of patients with progressive multiple sclerosis

Maria L. Elkjaer,Tobias Frisch,Richard Reynolds,Tim Kacprowski,Mark Burton,Torben A. Kruse,Mads Thomassen,Jan Baumbach,Zsolt Illes

DOI: https://doi.org/10.1186/s40478-019-0855-7

2019-12-01

Acta Neuropathologica Communications

Abstract:Abstract To identify pathogenetic markers and potential drivers of different lesion types in the white matter (WM) of patients with progressive multiple sclerosis (PMS), we sequenced RNA from 73 different WM areas. Compared to 25 WM controls, 6713 out of 18,609 genes were significantly differentially expressed in MS tissues (FDR < 0.05). A computational systems medicine analysis was performed to describe the MS lesion endophenotypes. The cellular source of specific molecules was examined by RNAscope, immunohistochemistry, and immunofluorescence. To examine common lesion specific mechanisms, we performed de novo network enrichment based on shared differentially expressed genes (DEGs), and found TGFβ-R2 as a central hub. RNAscope revealed astrocytes as the cellular source of TGFβ-R2 in remyelinating lesions. Since lesion-specific unique DEGs were more common than shared signatures, we examined lesion-specific pathways and de novo networks enriched with unique DEGs. Such network analysis indicated classic inflammatory responses in active lesions; catabolic and heat shock protein responses in inactive lesions; neuronal/axonal specific processes in chronic active lesions. In remyelinating lesions, de novo analyses identified axonal transport responses and adaptive immune markers, which was also supported by the most heterogeneous immunoglobulin gene expression. The signature of the normal-appearing white matter (NAWM) was more similar to control WM than to lesions: only 465 DEGs differentiated NAWM from controls, and 16 were unique. The upregulated marker CD26/DPP4 was expressed by microglia in the NAWM but by mononuclear cells in active lesions, which may indicate a special subset of microglia before the lesion develops, but also emphasizes that omics related to MS lesions should be interpreted in the context of different lesions types. While chronic active lesions were the most distinct from control WM based on the highest number of unique DEGs ( n = 2213), remyelinating lesions had the highest gene expression levels, and the most different molecular map from chronic active lesions. This may suggest that these two lesion types represent two ends of the spectrum of lesion evolution in PMS. The profound changes in chronic active lesions, the predominance of synaptic/neural/axonal signatures coupled with minor inflammation may indicate end-stage irreversible molecular events responsible for this less treatable phase.

neurosciences
Fast Rates to Bayes for Kernel Machines

Ingo Steinwart,C. Scovel

Abstract:
Segmental abnormalities of white matter microstructure in multiple sclerosis and neuromyelitis optica spectrum disorder identified by automated fiber quantification

Yan Xie,Shaolong Wu,Houming Su,Yihao Yao,Hongquan Zhu,Yan Zhang,Wenzhen Zhu

DOI: https://doi.org/10.1016/j.msard.2024.106147

IF: 4.808

2024-11-07

Multiple Sclerosis and Related Disorders

Abstract:Background Multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD) are different in pathogenesis, but both could lead to white matter (WM) microstructural damage. The aim of this study was to explore the differences in the patterns of WM fiber tract damage in relapsing-remitting MS (RRMS) and NMOSD by automated fiber quantification (AFQ). Materials and Methods Forty-one RRMS patients, 30 NMOSD patients and 30 healthy controls (HC) underwent MRI examination. AFQ was applied to identify and quantify 100 equally spaced nodes of specific WM fiber tracts for each participant. Measurements of fractional anisotropy (FA), mean diffusion (MD), axial diffusivity (AD) and radial diffusivity (RD) for each segment of a specific fiber tract were compared between RRMS, NMOSD and HC. Results The decrease in FA was found in 7 fiber tracts in entire tract comparison and 9 fiber tracts in pointwise comparison in RRMS patients. However, the FA in left thalamic radiation (TR) and right uncinate fasciculus showed significant differences between RRMS and HC only in the pointwise comparison, but not in the entire tract comparison. The MD, AD and RD of WM fiber tracts in RRMS patients were extensively increased both in the entire level and in the pointwise level. NMOSD patients showed significant FA decrease in left TR and callosum forceps minor (CF_minor), and significant RD increase in CF_minor in the pointwise level. In the pointwise comparison between RRMS and NMOSD, significant FA decrease was found in right inferior fronto-occipital fasciculus and bilateral inferior longitudinal fasciculus in RRMS patients, focal or widespread MD, AD and RD increase was found in multiple fiber tracts. Conclusion The AFQ approach is a more sensitive way to reflect WM microstructural abnormalities, revealing extensive WM microstructural damage in RRMS and limited WM fiber tract damage in NMOSD.

clinical neurology

Source of circulating progesterone in prepubertal ewes.

Myelin and axon pathology in multiple sclerosis assessed by myelin water and multi-shell diffusion imaging

Proteomics analysis of periplaque and chronic inactive multiple sclerosis lesions

History of diagnostic enzymology: a review of significant investigations.

Examining the relative contribution of slow-burning inflammation and chronic demyelination to axonal damage in chronic multiple sclerosis lesions

Comparing two versions of the Schedule for Evaluation of Individual Quality of Life in patients with advanced cancer

Evaluating brain damage in multiple sclerosis with simultaneous multi-angular-relaxometry of tissue

Multimodal Coherent Anti-Stokes Raman Scattering Microscopy Reveals Microglia-Associated Myelin and Axonal Dysfunction in Multiple Sclerosis-Like Lesions in Mice.

Seizures Worsen Stroke Outcome: New Evidence from a Large Sample

A lymphocyte–microglia–astrocyte axis in chronic active multiple sclerosis

Micro‐diffusely abnormal white matter: An early multiple sclerosis lesion phase with intensified myelin blistering

Digital Pathology Identifies Associations between Tissue Inflammatory Biomarkers and Multiple Sclerosis Outcomes

Advanced MRI Measures of Myelin and Axon Volume Identify Repair in Multiple Sclerosis

COMBINED USE OF NOVEL MR IMAGING AND FLUID BIOMARKERS REVEAL DETERMINANTS OF MYELIN AND AXONAL LOSS WITH AGING

Brain disconnectome mapping derived from white matter lesions and serum neurofilament light levels in multiple sclerosis: A longitudinal multicenter study

Axonal water fraction as marker of white matter injury in primary-progressive multiple sclerosis: a longitudinal study

Evolution of the thyrotropin receptor: a G protein coupled receptor with an intrinsic capacity to dimerize.

Neuroimaging assessment of facility-bound severely-affected MS reveals the critical role of cortical gray matter pathology: results from the CASA–MS case-controlled study

Molecular signature of different lesion types in the brain white matter of patients with progressive multiple sclerosis

Fast Rates to Bayes for Kernel Machines

Segmental abnormalities of white matter microstructure in multiple sclerosis and neuromyelitis optica spectrum disorder identified by automated fiber quantification